Heather Bresch, Mylan CEO (Pablo Martinez Monsivais, AP Images)

Hours af­ter block­buster patent win, My­lan asks the FDA to speed up an OK to mar­ket a gener­ic to Bio­gen’s Tec­fidera

Hours af­ter Bio­gen was hand­ed a key de­feat in fed­er­al court, los­ing patent pro­tec­tion that would have pro­tect­ed the multi­bil­lion-dol­lar fran­chise drug Tec­fidera to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.